Concourse Financial Group Securities’s Collegium Pharmaceutical COLL Stock Holding History

Concourse Financial Group Securities’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6	Closed	-$150	–	2291
2023 Q3	$134	Sell	6 -2	-25%	-$46	﹤0.01%	2264
2023 Q2	$171	Sell	8 -4,419	-100%	-$100K	﹤0.01%	2297
2023 Q1	$106K	Buy	+4,427	New	+$117K	0.01%	850
2021 Q4	–	Sell	-491	Closed	-$9.57K	–	2386
2021 Q3	$10K	Buy	491 +106	+28%	+$2.29K	﹤0.01%	1884
2021 Q2	$9K	Buy	385 +134	+53%	+$3.1K	﹤0.01%	1893
2021 Q1	$6K	Buy	251 +55	+28%	+$1.31K	﹤0.01%	1913
2020 Q4	$4K	Hold	196	–	–	﹤0.01%	1964
2020 Q3	$4K	Sell	196 -6	-3%	-$108	﹤0.01%	1845
2020 Q2	$4K	Buy	202 +65	+47%	+$1.27K	﹤0.01%	1737
2020 Q1	$2K	Hold	137	–	–	﹤0.01%	1868
2019 Q4	$3K	Buy	+137	New	+$2.28K	﹤0.01%	1752

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Concourse Financial Group Securities's COLL Position: Q4 2023 in Review

Concourse Financial Group Securities sold out of Collegium Pharmaceutical (COLL) in Q4 2023, closing a stake of 6 shares — an estimated $150 sold.

Concourse Financial Group Securities first reported a position in COLL in Q4 2019 and held it in 11 quarters. The position peaked at $106K in Q1 2023. 193 funds tracked by Wall St. Rank hold COLL as of Q4 2023.

Concourse Financial Group Securities reported no remaining Collegium Pharmaceutical position as of Q4 2023 after selling out during the quarter.
Concourse Financial Group Securities sold 6 Collegium Pharmaceutical shares in Q4 2023, an estimated $150.
Concourse Financial Group Securities first reported a position in Collegium Pharmaceutical in Q4 2019 and held it in 11 quarters.
Concourse Financial Group Securities's Collegium Pharmaceutical position peaked at $106K in Q1 2023.
193 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2023.

Based on Concourse Financial Group Securities's 13F filing for Q4 2023, filed 7 Feb 2024.